Financials
Financial year 2025
MAERTENS PHARMA ASSOCIES from Chimay, company number BE0821407282, closed financial year 2025 with a result of € 1,154 after tax. For that financial year MAERTENS PHARMA ASSOCIES recorded a gross margin of € 266,463 and equity of € 344,243. Compared with financial year 2024, the result moved from € 42,940 to € 1,154. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 344,243
▼ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1,154
▼ 97% vs 2024
Profit after tax over the fiscal year.
€ 79,448
▼ 5% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 52,500 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
2.5
Average over the fiscal year, from the social balance sheet.
€ 167,131
▲ 3% vs 2024
€ 66,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 39,785
▲ 270% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 74,315
▲ 40% vs 2024
€ 40,770 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 44,160
▲ 36% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 46,839
▲ 7% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 307,298 | € 287,771 | € 305,493 | € 266,463 | ▼ 13% |
| Profit after taxes | € 25,867 | € 29,155 | € 42,940 | € 1,154 | ▼ 97% |
| Equity | € 323,494 | € 352,649 | € 395,589 | € 344,243 | ▼ 13% |
| Total debts | € 386,774 | € 286,590 | € 174,744 | € 239,701 | ▲ 37% |
| Cash | € 133,034 | € 101,333 | € 83,277 | € 79,448 | ▼ 5% |
| Retained profit | € 317,294 | € 346,449 | € 389,389 | € 338,043 | ▼ 13% |
| Dividend | € 0 | € 0 | € 0 | € 52,500 | |
| Bank debt | € 266,768 | € 153,839 | € 52,922 | € 74,315 | ▲ 40% |
| Balance sheet total | € 710,268 | € 639,239 | € 570,333 | € 583,944 | ▲ 2% |
| Employees (FTE) | 2.8 | 2.8 | 2.5 | 2.5 |
Key figures of MAERTENS PHARMA ASSOCIES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MAERTENS PHARMA ASSOCIES?
What happened at MAERTENS PHARMA ASSOCIES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 1,154 (▼ 97% vs 2024). Source: NBB ↗
- New establishment in Chimay. KBO
- Start of the company according to the CBE. KBO
In short
From € 25,867 profit in 2022 to € 1,154 profit in 2025.
Paid € 98,941 in corporate taxes since 2022.
Best year ever: 2024, with € 42,940 profit.
On average € 106,600 of value added per employee in 2025.
Management
Behind MAERTENS PHARMA ASSOCIES are DEBORA MUSARDO and JULIEN MAERTENS. The same people are also behind DEBS ET JU.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Place Léopold(CH) 2
6460 Chimay
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0821.407.282
- VAT number
- BE 0821.407.282
- Registered office
- Place Léopold(CH) 2, 6460 Chimay
- Names & denominations
- MAERTENS PHARMA ASSOCIES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 December 2009
- Peppol
- Active · Active since 5 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten